Articles tagged with Crohn Disease
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A signaling protein, GM-CSF, plays a vital role in fighting bacterial infections and inflammation in the intestinal tract. Its deficiency is linked to increased susceptibility to persistent gut infection, severe inflammation, and disease duration.
Researchers have identified genetic risk markers for post-infectious irritable bowel syndrome (PI-IBS) in victims of the Walkerton tainted drinking water tragedy. The study, led by McGill PhD Alexandra-Chloé Villani, found that genetic factors play a critical role in the development of PI-IBS.
A new study published in Journal of Biological Chemistry found that Vitamin D deficiency can contribute to Crohn's disease. The researchers discovered that Vitamin D acts directly on genes involved in fighting intestinal bacteria and immune responses. Siblings of patients with Crohn's disease may benefit from ensuring they are vitamin ...
A clinical trial at the University of Western Ontario aims to improve patient treatment for Crohn's disease by evaluating a new combination therapy approach. The REACT study will compare conventional management strategies to a newer paradigm featuring early use of immunosuppression and anti-metabolites.
Researchers have identified a critical imbalance of regulatory cells and increased 'attack' cells in people with Crohn's disease and ulcerative colitis. This imbalance can be addressed through diet and lifestyle changes, reducing the need for colonoscopies.
A study found that patients with IBD, particularly those on thiopurine medications, may be at higher risk for non-melanoma skin cancer. The study also showed that recent use of immunosuppressive medications was associated with increased risk of NMSC.
A cohort study of 19,486 patients with inflammatory bowel disease found a significant increased risk of lymphoma associated with thiopurine use. The absolute cumulative risk remains low in young patients, but elderly patients and prolonged treatment periods warrant further investigation.
A study has found that a mutation in the NOD2 gene may predispose individuals to Crohn's disease by impairing the immune system's ability to recognize and fight off mycobacteria. The research, published in the Journal of Experimental Medicine, highlights the potential for new therapeutic approaches to combat the disease.
Researchers presented data on the effectiveness of monoclonal antibodies in treating Crohn's disease and preventing C. difficile recurrence, showing improved clinical outcomes and safety profiles.
Researchers explore health outcomes of IBD, finding increased radiation exposure among patients, especially those with Crohn's disease. Growth hormone therapy shows promise in reducing symptoms and improving disease activity in pediatric CD patients.
Researchers at Brown University found MR enterography to be an effective tool for evaluating and guiding treatment of Crohn's Disease patients without exposing them to unnecessary radiation. The test was shown to provide valuable information for guiding patient management, with physicians overwhelmingly preferring it over CT scans.
Researchers have discovered new genes involved in Crohn's disease using a novel approach that combines statistical tools and automated gene-hunting techniques. The study identified genes on the same biological pathways as those already known to be relevant to the biology of Crohn's disease.
A new study found that infliximab was effective at preventing endoscopic, clinical and histological postoperative recurrence of Crohn's disease. The treatment significantly reduced the rate of endoscopic recurrence (9.1%) compared to placebo (84.6%).
Researchers at McGill University have discovered a DNA variation in the NLRP3 gene that increases susceptibility to developing Crohn's disease. The study reveals how a faulty bacterial sensor disrupts the digestive immune system's defense against harmful bacteria, leading to chronic inflammation and disease.
A Mayo Clinic-led study finds that infliximab administered alone or in combination with azathioprine is more effective for moderate to severe Crohn's disease than azathioprine alone. The study demonstrates improved patient outcomes, including higher remission rates and mucosal healing.
Research finds disabled gut cells linked to Crohn's disease, with altered genetic activity leading to increased hormone production. The study suggests a potential role for autophagy and Atg16L1 in Paneth cell function, shedding light on the complex mechanisms behind the inflammatory bowel disorder.
A study has identified a new gene that may play a key role in the development of pediatric-onset inflammatory bowel disease. The gene, TNFRSF6B, is involved in regulating inflammation and its activity has been linked to the severity of the disease.
Researchers are developing new treatments targeting Crohn's disease by blocking autoimmune responses and strengthening the intestinal lining. The goal is to provide more effective options for patients who have lost response to current treatments.
Researchers at Montreal Heart Institute and Mount Sinai Hospital discover 21 new genetic risk factors associated with Crohn's disease, more than doubling the amount of genetic information about the disease. This breakthrough study offers hope for better-targeted therapy for millions of people with inflammatory bowel diseases.
An international team of researchers has identified 21 new genetic risk factors for Crohn's disease, building on earlier studies that linked the disorder to disruptions in autophagy and immune system response. The findings, published in Nature Genetics, may lead to novel therapies and prevention strategies.
A study published in Nature Genetics has identified over 30 genetic regions associated with Crohn's disease, revealing surprising links between the condition and other common diseases like asthma. The research also highlights the complexity of the disease, suggesting hundreds of genes may be involved.
Researchers are investigating the effectiveness of dietary changes and complementary medicine to control inflammatory bowel diseases (IBD) flare-ups. The studies aim to find alternative treatments with fewer side effects, targeting stress reduction and gut bacteria balance.
A new analysis of REMICADE for ulcerative colitis found that over 60% of patients achieved clinical response at week 8, with significant improvements maintained at week 30. The study also reported significant improvements in disease remission and mucosal healing.
A large-scale study published in Journal of the American Medical Association finds that omega-3 fatty acids offer no benefit for preventing relapse in Crohn's disease. However, patients who took omega-3 supplements experienced significantly lower triglyceride levels, a risk factor for heart disease.
A large-scale study found that omega-3 free fatty acid supplements did not significantly reduce the risk of relapse in patients with Crohn disease. The research, published in JAMA, evaluated the effectiveness of high-dose omega-3 fatty acids as maintenance therapy in patients with Crohn disease in remission.
A large multicenter study suggests new genetic markers for Crohn's disease, specifically affecting the Ashkenazi Jewish population. The study found evidence of genes causing familial Crohn's Disease on chromosomes 1 and 3, as well as a previously unidentified region on chromosome 13.
A case report describes a woman with small bowel endometriosis who presented symptoms similar to Crohn's disease. Histopathological examination confirmed the diagnosis of Crohn's disease, highlighting the need for accurate differential diagnosis in clinical practice.
Researchers found that combined immunosuppression therapy was more effective than conventional treatment in inducing remission and reducing corticosteroid use in patients with newly diagnosed Crohn's disease. The study showed that early intensive treatment could lead to better outcomes, with higher remission rates at weeks 26 and 52.
Researchers found that a new 'top-down' therapy approach significantly improved disease remission rates and reduced steroid use in Crohn's patients. The two-year study showed 60% of top-down subjects were symptom-free by week 26, compared to 36% on traditional step-up treatment.
Researchers found that Mycobacterium paratuberculosis, a bacterium causing cattle illness, triggers Crohn's disease in humans by releasing a molecule preventing white blood cells from killing E.coli bacteria. The team suggests dairy products, including cow milk, may be the entry point for this bacterium.
Two studies found that genetic variants in metabolic genes impact cholesterol metabolism, while Crohn's disease contributes to atherosclerosis. Researchers also identified a potential treatment for bile acid disorders using FXR targeted therapies.
REMICADE has been used to treat more patients worldwide than all other anti-TNF-alpha agents combined. The treatment of patients with inflammatory diseases, such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis and Crohn's disease, has been transformed by the availability of REMICADE.
Researchers used capsule endoscopy to evaluate unexplained gastrointestinal bleeding and found six previously undiagnosed cases of Crohn's disease. The study highlights the tool's ability to detect inflammation in the small intestine, which can be missed by colonoscopies.
A study published by the American Society for Gastrointestinal Endoscopy found that capsule endoscopy identified Crohn's disease recurrence in 62% of patients, compared to 25% with colonoscopy. This led to changes in therapy for more than half of the patients studied.
A recent study published in The ISME Journal reveals that a specific group of E. coli bacteria is associated with chronic intestinal inflammation in patients with Crohn's disease. Researchers found an increased level of invasive E. coli bacteria in inflamed areas of the small intestine, suggesting a potential causal link to the disease.
Researchers at Children's Hospital of Philadelphia identified a gene variant associated with an increased risk of Crohn's disease in children. The study found that 64% of children with the disease had a specific variant form of the ATG16L1 gene, compared to 52% of healthy children.
A new therapy, certolizumab pegol, has been found to be effective in easing symptoms of patients with active Crohn's disease. The treatment was shown to improve clinical symptoms in both short-term and long-term maintenance therapies, offering a potential new option for managing the condition.
Patients with ankylosing spondylitis who received REMICADE showed significant improvement in spinal mobility and reduced spinal inflammation over two years. This study found that REMICADE-treated patients experienced sustained reductions in spinal inflammation, as detected by magnetic resonance imaging (MRI), compared to placebo group.
A new study demonstrates the value of PET/CT in diagnosing and monitoring Crohn's disease, offering a non-invasive alternative to invasive endoscopy. The scan can accurately identify active disease and detect severe lesions, reducing the need for costly and side-effect-ridden treatments.
A Phase II clinical trial suggests that extracorporeal photopheresis (ECP) is effective in treating clinically active Crohn's disease, with a 50% response rate after 3 months of treatment. Patients who responded to ECP therapy experienced notable improvements in disease symptoms and signs within six weeks.
Researchers discovered that CEACAM6 facilitates adhesion of adherent-invasive E. coli (AIEC) bacteria to the intestinal epithelial cells' brush border in patients with Crohn's disease. This adhesion is dependent on CEACAM6 expression, which is increased in Crohn's disease patients after infection.
A long-term study of REMICADE found that patients with moderate to severe ulcerative colitis maintained improved clinical symptoms for up to two years after treatment. The study showed that 92% of patients had mild or no disease activity at week 56 and 97% at week 104, indicating sustained efficacy.
A study by Mayo Clinic found that adalimumab is an effective treatment for adults with Crohn’s disease who do not respond to infliximab therapy. The therapy was shown to achieve remission in 21% of patients and improve symptoms in 52%.
Researchers have discovered a new genetic locus associated with an increased risk of developing Crohn's disease, a chronic inflammatory disorder. The study, published in PLOS Genetics, found that a specific region on chromosome 5 is linked to the disease.
A consortium of Canadian and American researchers have identified three major genetic risk factors for Crohn's disease: PHOX2B, NCF4, and ATG16L1. These findings highlight biological pathways not previously thought to play a role in the disease, including altered reactive oxygen species production and autophagic processes.
A study published in Nature Genetics identifies PHOX2B, NCF4, and ATG16L1 as genetic risk factors for Crohn's disease. The research highlights the role of neuroendocrine cells and altered reactive oxygen species production in increasing disease susceptibility.
Researchers identify three genetic variants associated with an increased risk of Crohn's disease, including PHOX2B, NCF4, and ATG16L1. These discoveries offer new insights into the biological pathways underlying the disease and may lead to more effective therapies.
A research team has identified several novel genetic variations associated with the risk of Crohn's disease, which could improve understanding of the disease process and lead to new therapies. The study found that one of the newly identified genes, ATG16L1, plays a crucial role in autophagy, a biological pathway involved in inflammation.
Patients treated with REMICADE experienced significant improvements in work and daily activities, with mean increases of 2.9-3.1 points compared to little improvement in placebo-treated patients. Psoriasis is an inflammatory disorder that can cause physical pain and emotional distress, impacting productivity.
A Penn State College of Medicine pilot study found that 89 percent of participants with diagnosed Crohn's disease showed improvement with low-dose naltrexone therapy, while 67 percent achieved remission. This novel approach offers a simple and safe treatment option for the chronic inflammatory disorder.
Research reveals IBD increases risk of premature birth and low birthweight by almost twice, while also boosting caesarean section rates and congenital defects
A CCFA survey reveals that 65% of ulcerative colitis patients are less than fully compliant with first-line therapies, resulting in a significant impact on their quality of life. The most common reasons for non-compliance were dosing frequency, number of pills, and medication inconvenience.
A recent study has identified a new genetic link to Crohn's disease, revealing that mutations in the IL-23 receptor gene are strongly associated with the condition. The researchers found that one type of mutation provides significant protection, paving the way for more individualized and effective treatments.
A study by Yale researchers has identified a gene variant associated with Crohn's disease, which may offer new therapeutic targets for the condition. The discovery was made in collaboration with international researchers who scanned the genome of over 300,000 individuals to identify genetic components of inflammatory bowel disease.
The study identified two genes linked to Crohn's disease: Nod2 and IL-23R. This discovery may lead to improved diagnosis and targeted drug therapies for patients with Crohn's disease.
An international team of researchers has identified a novel gene mutation linked to Crohn's disease and ulcerative colitis, which may offer a new pathway for tracking the disease process and potential drug treatments.
A new genetic link has been found for Crohn's disease, revealing a crucial target for drugs that might better manage the condition. The discovery of a specific gene variant confers significant protection against IBD, suggesting therapies targeting the IL-23 pathway may lead to more individualized treatments.
Researchers have discovered a genetic risk factor for inflammatory bowel disease (IBD) that may confer protection against Crohn's disease and ulcerative colitis. The study highlights a major inflammatory pathway and identifies potential targets for therapies, including the manipulation of IL-23 pathway.
A recent study by Penn State researchers found that 89% of patients with diagnosed Crohn's disease showed improvement with therapy using naltrexone, while 67% achieved remission of symptoms. The treatment has been shown to be simple, safe, and cost-effective compared to traditional steroid treatments.
Researchers investigated TLR5 gene variants and their relationship to Crohn's Disease, finding effects on both Jews and non-Jews. The study highlights the importance of considering ethnicity in future investigations for better therapies.